Related Experiment Video

Updated: May 15, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer

Minu K Srivastava1, Steven Dubinett, Sherven Sharma

  • 1Department of Medicine; UCLA Lung Cancer Research Program; David Geffen School of Medicine; University of California at Los Angeles; Los Angeles, CA USA ; Molecular Gene Medicine Laboratory; Veterans Affairs Greater Los Angeles Healthcare System; Los Angeles, CA USA.

Oncoimmunology
|December 25, 2012
PubMed

Insights

Depleting myeloid-derived suppressor cells (MDSCs) enhances anti-tumor immune responses. This strategy improved therapeutic vaccination outcomes in a murine lung cancer model, suggesting potential for other cancers.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Myeloid-derived suppressor cells (MDSCs) are key regulators of immune responses.
  • MDSCs suppress cytotoxic natural killer (NK)-cell and T-cell effector functions.
  • MDSCs are known to promote tumor growth and progression.

Purpose of the Study:

  • To investigate the therapeutic potential of MDSC depletion in cancer treatment.
  • To evaluate the impact of MDSC depletion on vaccination efficacy in a lung cancer model.

Main Methods:

  • Utilized a murine model of lung cancer.
  • Employed strategies to deplete MDSCs within the tumor microenvironment.
  • Assessed therapeutic responses to vaccination following MDSC depletion.

Main Results:

  • Depletion of MDSCs significantly improved therapeutic responses to vaccination.
  • This approach demonstrated efficacy in a preclinical lung cancer model.
  • MDSC suppression is a critical mechanism hindering anti-tumor immunity.

Conclusions:

  • Targeting MDSCs represents a promising strategy to enhance anti-tumor immunity.
  • MDSC depletion can overcome immune suppression and improve cancer vaccine efficacy.
  • This approach may be beneficial for treating tumors characterized by significant MDSC activity.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...